2017 UK Endocrine Function Testing Market: Future Horizons and Growth Strategies--Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities

March 2017 | 269 pages | ID: U49CB0E05F0EN
Venture Planning Group

Abstracts

This new 269-page report from VPGMarketResearch.com provides a comprehensive analysis in the UK endocrine function market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares and strategic profiles of leading suppliers.The report provides test volume and sales forecasts by country and market segment for the following assays: Cortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH/IO PTH, Prolactin, T3, T3 Uptake, Free T3, T4, Free T4, TBG, Testosterone, Thyroglobulin Ab, TPO Ab and TSH.During the next five years, the endocrine function testing market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition.

Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.This report is a unique market and technology assessment designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study explores future trends; provides test volume and sales forecasts; compares features of leading analyzers; and profiles key competitors.

Contains 269 pages and 16 tables

Contents

I. INTRODUCTION

II. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. Major 1nfectious Disease Tests
  1. CAMPYLOBACTER
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  2. CRYPTOSPOR1D1UM
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  3. E. COL1
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  4. ENTERO6RUSES
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  5. RH1NO6RUSES
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  6. ROTA6RUS (REO6RUS)
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  7. SALMONELLOS1S
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  8. SH1GELLOS1S
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  9. 6BR1O
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  10. YERS1N1A
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
B. 1nstrumentation Review of Leading Analyzers Marketed by Abbott, Beckman Coulter/Danaher, BioMerieux, Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other Suppliers
C. Emerging Diagnostic Technologies
  1. MOLECULAR D1AGNOST1CS
  2. MONOCLONAL ANT1BOD1ES
  3. 1MMUNOASSAYS
  4. D1FFERENT1AL L1GHT SCATTER1NG
  5. 1NFORMAT1ON TECHNOLOGY
  6. ART1F1C1AL 1NTELL1GENCE
  7. L1POSOMES
  8. FLOW CYTOMETRY
  9. CHROMATOGRAPHY
  10. D1AGNOST1C 1MAG1NG
  11. GEL M1CRODROPLETS
  12. OTHER

VIII. UK: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES

ALTERNATIVE MARKET PENETRATION STRATEGIES

A. 1nternal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
  1. MARKET1NG APPROACHES
  2. PRODUCT COMPLE11TY
  3. CUSTOMER PREFERENCE
  4. ESTABL1SHED SUPPL1ERS
  5. EMERG1NG SUPPL1ERS
  6. MAJOR TYPES OF D1STR1BUTORS
  7. MARKET SEGMENTAT1ON

POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

COMPETITIVE ASSESSMENTS

Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix/Erba
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Fujirebio
Grifols
Hologic/Gen-Probe
1D Biomedical/GSK
Kreatech/Leica
Lonza
Ortho-Clinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wallac/PE
Wako

L1ST OF TABLES

Major Companies Developing or Marketing Campylobacter Tests
Major Companies Developing or Marketing Enterovirus Tests
Major Companies Developing or Marketing Rotavirus Tests
Major Companies Developing or Marketing Salmonella Tests
Major Companies Developing or Marketing Shigella Tests
Major Companies Developing or Marketing Yersinia Tests
U.K. Campylobacter Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K. Campylobacter Diagnostics Sales by Major Supplier
U.K. Cryptosporidium Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K. Cryptosporidium Diagnostics Sales by Major Supplier
U.K. E. Coli Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K. Enterovirus Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K. Rhinovirus Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K. Rotavirus Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K. Rotavirus Testing Market Diagnostics Sales by Major Supplier
U.K. Salmonella Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K. Shigella Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K. Shigella Testing Market Diagnostics Sales by Major Supplier
U.K. 5ibrio Test 5olume and Diagnostics Sales Forecast by Market Segment
U.K. Yersinia Test 5olume and Diagnostics Sales Forecast by Market Segment